During the past decade, Whitby Group Practice conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whitby Group Practice" #1 sponsor was "Pfizer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored and "Galderma R&D" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Whitby Group Practice" are "Cardiovascular Disease" (2 trials), "Acne" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Whitby Group Practice" in a lesser frequency.

Most popular intervention types in "Whitby Group Practice" are "Drug" (3 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Evolocumab" (1 trials), "Non-interventional" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Whitby Group Practice" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Whitby Group Practice". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Whitby Group Practice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Whitby Group Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".